Also in this playlist...
This transcript is automatically generated
Don't need some we don't have to wait critical probably -- -- right there at the New York Stock Exchange and we have the confirmation today about a story.
That broke Friday and that is that sprint is turning Japanese.
And that's right we've taken a look at spring as it was actually higher -- the date certain to.
The red late in the day but that's absolutely right Softbank.
Now looking to acquire about 70% spread twenty billion dollar deal this is the largest obviously deal of its kind where Japanese company.
Coming in for an American company disparate like -- it.
Because this document is obviously financials mixed today -- the clear -- no doubt about it Citigroup debate expectations to get the day going.
Yeah I -- -- if you're sitting his shareholding -- really happy today you're seeing obviously got -- the beach.
On on revenue and earnings and now a lot of folks are looking forward to tomorrow's numbers from Goldman Sachs and and the talk on Wall Street is that those will be gets down.
OK what about Barclays Barclays likes the drug sector of course we -- -- -- looking very good.
But Barclays is raising the price target on five companies and entire sample.
We've got Gilead slightly down with the rest moving higher.
That's right and Spicer actually hit a new 52 week high Eli -- you're showing earlier with a cancer -- but these.
Names in particular -- jumping on the Barclays upgrade and several.
That's why can't hide that doesn't -- to -- -- upping the price -- -- news.com.
The -- index supplies and really about today.
But we saw oil cancel the.
Filter by section